Bioperfectus launched the first H7N4 avian influenza Real-Time PCR in China. In the same year, Bioperfectus was invited to be the official supplier of infectious disease testing during the "Belt and Road Forum for International Cooperation" in Beijing, China.
From 2020 until nowadays
Bioperfectus has launched a series of diagnostic pipelines including respiratory infectious diseases, sexually transmitted diseases, vector-borne diseases, zoonosis infectious diseases, gastrointestinal infectious diseases, life science，nucleic acid extraction solutions and real-time PCR system to assist the globe in fighting against the infectious diseases.
In August 2020
Bioperfectus Nucleic Acid Extraction Kit (Magnetic Bead Method), Bioperfectus Nucleic Acid Isolation Kit (Silica Based Spin Column Method), Bioperfectus Nucleic Acid Extraction System (SSNP-2000B, SSNP-3000A, SSNP-9600A) obtained FDA Listed.
On July 9, 2020
Bioperfectus COVID-19 Coronavirus Real Time PCR Kit was granted of World Health Organization Emergency Use Listing (WHO-EUL).
On June 18, 2020
Bioperfectus COVID-19 Coronavirus Real Time PCR Kit was granted an Emergency Use Authorization by the US Food and Drug Administration (EUA-FDA).
On June 1, 2020
International Sales and Marketing Division was established.
On May 5, 2020
COVID-19 Coronavirus Real Time PCR Kit developed by Bioperfectus was certified by the Australian Drug Administration Therapeutic Goods Administration (TGA);
On March 6, 2020
Bioperfectus COVID-19 Coronavirus Real Time PCR Kit was awarded the CE certification;
a leading molecular diagnostic solution provider